Literature DB >> 34529150

[Technology assessment of digital health applications for reimbursement decisions].

Reinhard Jeindl1, Claudia Wild2.   

Abstract

BACKGROUND: For most digital health applications (DiGA) only limited evidence of benefit is available. Currently available assessment frameworks do not cover all domains of a full health technology assessment (HTA). Additionally, technology-specific aspects are required for the evaluation of DiGA. This work aimed to analyze the available assessment frameworks and design an evaluation process for DiGA.
METHODS: By a systematic literature search six assessment frameworks for DiGA were selected and analyzed. A hand search for strategies on DiGA of selected countries was conducted.
RESULTS: Of the analyzed assessment frameworks four described study designs. One assessment framework proposed a risk classification of DiGA. Aspects of artificial intelligence were assessed by one assessment framework. The analyzed countries have differing strategies for reimbursement of DiGA.
CONCLUSION: Assessment frameworks for DiGA are very heterogeneous. There are efforts to find regulations for DiGA on a national level. When evaluating DiGA, a staged approach considering risk classes with subsequent evaluation of relevant HTA aspects is recommended.
© 2021. The Author(s).

Entities:  

Keywords:  Assessment Frameworks; Digital Health; Digital Health Applications; MHealth; Reimbursement

Year:  2021        PMID: 34529150     DOI: 10.1007/s10354-021-00881-3

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  2 in total

1.  Health technology assessment frameworks for eHealth: A systematic review.

Authors:  Christiaan Vis; Leah Bührmann; Heleen Riper; Hans C Ossebaard
Journal:  Int J Technol Assess Health Care       Date:  2020-04-16       Impact factor: 2.188

2.  Development of a health technology assessment module for evaluating mobile medical applications.

Authors:  Magdalena Ruth Moshi; Rebecca Tooher; Tracy Merlin
Journal:  Int J Technol Assess Health Care       Date:  2020-05-18       Impact factor: 2.188

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.